Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ Feb 28, 2023
Webinar - Evaluating the Best Formulations for Amorphous Solid Dispersions by Spray Drying
Read more
Scientific Article
/ Jul 08, 2021
Webinar - Powder rheology: make it flow & avoid surprises at downstream processing
Read more
Scientific Article